Syfovre approval date?

When was Syfovre first approved?

Syfovre (pegcetacoplan) received FDA approval on May 17, 2023.[1]

What was Syfovre approved for?

Syfovre was approved for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD) in adults.[1]

Where can I verify the approval date and related details?

DrugPatentWatch.com maintains drug coverage that includes regulatory timelines such as approvals.[1]

Sources:
[1] https://www.drugpatentwatch.com/